SCHEMBL6784780

SCHEMBL6784780

COc1cccc(-c2cccc3[nH]c4cnn(C)c4c(=O)c23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.44
WDR77 Q9BQA1 1/20 0.44
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
BRD4 O60885 2/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
PLAT P00750 1/20 0.40
CHEK1 O14757 1/20 0.39
WEE1 P30291 1/20 0.39
DCLK1 O15075 1/20 0.39
MAP4K4 O95819 1/20 0.39
CSF1R P07333 1/20 0.39
PIM1 P11309 1/20 0.39
CSNK1D P48730 1/20 0.39
CDK5 Q00535 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6788209 0.89 PARP1 (0.42) PRMT5WDR77ALDH1A1LMNAMEN1
SCHEMBL6784847 0.84 CDK4 (0.39) BRD4GAACHEK1WEE1MAP4K4
SCHEMBL6785377 0.81 PRMT5 (0.47) PRMT5WDR77ALDH1A1BRD4GAA
SCHEMBL6784727 0.79 KDR (0.43) PRMT5WDR77MEN1KMT2ACHEK1
SCHEMBL6782186 0.79 CDK4 (0.38) GAACHEK1WEE1CLK4KDR
Hydrochloric Acid SCHEMBL6785628 0.78 KDR (0.42) PRMT5WDR77MEN1KMT2ACHEK1
SCHEMBL14255815 0.73 ABCG2 (0.56) ALDH1A1MEN1GAAMAPTRAB9A
SCHEMBL6788043 0.73 FEN1 (0.42) ALDH1A1MEN1GAAKMT2ACHEK1
SCHEMBL6785738 0.72 POLB (0.39) PRMT5WDR77ALDH1A1LMNAMEN1
SCHEMBL6782106 0.72 ABCG2 (0.43) PRMT5WDR77ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG PRMT5 612/4885WDR77 535/4885ALDH1A1 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.